MEDIUM confidence: 100% data completeness, but the composite (52) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Net insider -$2.4M over 180 days (3 open-market buys, 4 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Avg target $373 (last qtr, 8 analysts) → $385 (last mo, 3) (+3.3%).
Buy-rated share 86% → 73% over ~3 months (-12pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $4.35 | $4.48 | +3.0% |
| May 2026 | $4.82 | $4.75 | -1.5% |
| Feb 2026 | $4.05 | $4.08 | +0.7% |
| Nov 2025 | $3.79 | $3.84 | +1.3% |
| Aug 2025 | $3.85 | $4.00 | +3.9% |
| May 2025 | $4.11 | $4.42 | +7.5% |
| Feb 2025 | $3.50 | $3.73 | +6.6% |
| Nov 2024 | $3.23 | $3.34 | +3.4% |
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $214.0B— | $238.6B+11.5% | $262.2B+9.9% | $294.0B+12.1% | $321.3B+9.3% |
| EPS (dil.) | $7.39— | $8.04+8.8% | $8.53+6.1% | $7.53-11.7% | $7.96+5.7% |
| Free Cash Flow | $2.2B— | $2.2B-1.0% | $3.5B+56.5% | $3.0B-13.2% | $3.2B+7.0% |
| Gross Margin | 2.9% | 3.2%+0.3pp | 3.0%-0.2pp | 3.0%+0.0pp | 3.2%+0.2pp |
| Operating Margin | 1.3% | 1.2%-0.1pp | 0.9%-0.2pp | 1.0%+0.1pp | 1.1%+0.1pp |
| Net Margin | 0.7% | 0.7%-0.0pp | 0.7%-0.0pp | 0.5%-0.2pp | 0.5%-0.0pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 4.6%/yr (revenue basis).
Base free cash flow $3.2B (avg FY2023–FY2025; latest year $3.2B) · equity value $63.4B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 52 indicates a neutral outlook for COR, with the long-term and short-term scores closely aligned. The stock scores high on profitability, driven by an exceptionally high ROE of 106.4%, and exhibits relatively low risk with a beta of 0.6. However, it trades at a premium, as reflected in its value score, with a P/E of 24.6 and P/B of 21.0, and its growth score is moderate, with revenue growth of 9.3% and EPS growth of 5.5%. Momentum is mildly positive, with a 3-month return of 7.7%.